Spain's Grifols said on Friday the latest results from a clinical trial of its Alzheimer's treatment show positive effects by achieving a reduction of the disease's progression in patients with mild and moderate conditions.
... Not cool. In Alaska, a dentist is accused of fraud, unnecessarily sedating patients, and performing a dental procedure on a woman while riding a wheeled, motorized hoverboard, authorities say. Seth Lookhart, 34, is charged with felony Medicaid fraud and reckless endangerment.
A former patient testified Wednesday at his trial that she was angered when an investigator ... Alexion Pharmaceuticals Inc said on Friday its board of directors had unanimously rejected hedge fund Elliott Management's push for a "proactive sale" process of the entire company because it would not be in the best interest of shareholders.
... The U.S. Food and Drug Administration on Friday approved Amgen Inc's biosimilar copy of Johnson & Johnson's blockbuster rheumatoid arthritis drug, Remicade, according to the regulator's website.
... The United States recorded 15 measles cases over about a month as of Dec. 5, taking the total cases for the year to 1,276 in the worst outbreak since 1992, the Centers for Disease Control and Prevention said on Friday.
... (Reuters Health) - Air pollution has often been linked with increased heart disease risk, but a "natural experiment" involving travelers to a city much more polluted than their own offers clues to how it may harm blood vessels over time, researchers sa... ... U.S. Food and Drug Administration staffers reviewing Correvio Pharma Corp's heart drug said on Friday they did not believe the benefits of the therapy outweighed its risks, sending the company's shares down nearly 38%.
... Germany's Bayer has agreed with plaintiffs to postpone its next two U.S. lawsuits over the alleged cancer-causing effects of its glyphosate-based **** killers to allow more time for talks on a settlement.
... Biohaven Pharmaceutical said on Friday it would continue its late-stage study of experimental treatment for the symptoms of Alzheimer's on the recommendation of an independent data-monitoring committee, sending its shares up 11.6%.
... The Swiss government approved on Friday health insurance coverage for CAR-T cell therapies from Novartis and Gilead Sciences, which can cost hundreds of thousands of dollars per patient.
...
Archive for the ‘Health Articles’ Category
Grifols says trial shows positive effects in slowing Alzheimer’s
Alaska dentist rode hoverboard while performing procedure, prosecutors say
Alexion Pharma rejects Elliott’s push for ‘proactive sale’
FDA approves Amgen’s biosimilar to J&J’s rheumatoid arthritis drug
U.S. recorded 15 cases of measles over the past month
Brief visit to severely polluted city can up biomarkers of heart disease
Correvio slumps after FDA staffers say benefits of heart drug do not outweigh risks
Bayer reaches agreement to postpone more glyphosate lawsuits for settlement talks
Biohaven Pharma to continue late-stage study of Alzheimer’s treatment
Swiss approve insurance cover for Novartis, Gilead cell therapies